We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ATHXQ market cap is 61.72. The company's latest EPS is USD -1.1752 and P/E is 0.00.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 24.91M | 5.63M | 1.44M | 5.51M | 5.33M |
| Operating Income | -25.05M | -45.49M | -78.33M | -87.06M | -77.01M |
| Net Income | -24.28M | -44.58M | -78.77M | -86.96M | -72.53M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 61.73M | 41.67M | 59.71M | 60.18M | 27.73M |
| Total Liabilities | 18.61M | 18.4M | 28.35M | 43.82M | 51.58M |
| Total Equity | 43.12M | 23.27M | 31.36M | 16.37M | -23.85M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.35M | -35.33M | -61.81M | -76.19M | -58.95M |
| Investing | -915k | -579k | -1.16M | -1.36M | -262k |
| Financing | 36.01M | 19.89M | 79.48M | 63.41M | 30.84M |
| Market Cap | 61.72 |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 61.72M |
| Average Volume (1 week) | 9.2k |
| Average Volume (1 Month) | 8.48k |
| 52 Week Change | -99.99% |
| 52 Week High | 0.0425 |
| 52 Week Low | 0.000001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Athersys Inc New (CE) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.athersys.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
